Antibody conjugates form a foundation for many research, diagnostic, and therapeutic applications. Despite the robustness and efficiency of existing antibody conjugation techniques, the challenge of obtaining homogeneous products remains. Here, we developed a versatile modular method for site-directed antibody conjugation using the small protein ubiquitin. We show that ubiquitin, when fused to antibodies or antibody fragments, is conjugated using in vitro ubiquitin ligation with an average efficiency of 95%. We effectively applied this method, which we named ubi-tagging, to conjugate chemically-synthesized ubiquitin with a site-specifically incorporated payload (fluorophore) to ubi-tagged antibodies. Additionally, we show that this method efficiently generates di-, tri-, and multi-valent antibody complexes, including a bi-specific T cell activator and a DC-targeting antibody for the induction of an antigen-specific immune response. The combined use of both recombinant ubi-tags and synthetic ubiquitin allows homogeneous site-directed antibody conjugation with defined conjugates incorporating precise functionalities while retaining antibody functionality.